OffTheBUS

24/7 Live News Portal

Reserve Canada 114 million vaccines from J&J and Novavax


Canada has other agreements with Pfizer and Moderna that will allow it to obtain up to 190 million doses of experimental vaccines.

OTTAWA.

Canada announced today that he signed agreements with the Novavax Americans and Johnson & Johnson to make sure tens of millions of doses his vaccine projects against him covid-19 in case your effectiveness.

The agreements in principle they are added to other two similar that he had previously signed with the Americans Pfizer and Modern, which will allow Canada get up 190 million doses of experimental vaccines.

The 76 million doses from biotech Novavax’s NVX-CoV2373 project, which has just started phase 2 trials, could be delivered in the second quarter of 2021 if the vaccine finally hits the market.

About 38 million people live in Canada.

Johnson & Johnson has pledged to supply Canada with up to 38 million doses of its candidate vaccine Ad26.COV2.S, Prime Minister Justin Trudeau explained at a press conference.

The “most recent vaccine trials” from these two companies are “promising,” Trudeau said.

All of our agreements with Pfizer, Moderna, Novavax and Johnson & Johnson regarding a new vaccine will allow Canada to have access to at least 88 million doses and options to have tens of millions more, “said the president.

The trials of the experimental vaccines of the US Pfizer and Moderna are already in phase 3, the most advanced.

We have wanted to sign agreements with different companies because we do not really know which will be the first to develop a vaccine or where it will come from, “said the prime minister after visiting the new biofabrication facilities of the Center for Research in Human Health Therapeutics, in Montreal. .

The Donald Trump administration announced in early July that it had awarded $ 1.6 billion to Novavax for its vaccine project, guaranteeing the United States the priority of 100 million first doses in case of proven efficacy.

Maryland-based biotech Novavax has already signed partnership or dose supply agreements with the UK, Japan and India.

We are moving forward with the clinical development of NVX-CoV2373 with a strong sense of urgency in our efforts to produce a vaccine that protects the world, “said Novavax President Stanley Erck.

In addition to Pfizer and Moderna, other laboratories are already conducting phase 3 trials, such as Britain’s AstraZeneca and several Chinese companies.

Canada accumulated almost 128 thousand cases of coronavirus and some 9,150 deaths on Monday.

pleca ultima hora

jrr




www.excelsior.com.mx